NCT06434922

Brief Summary

The goal of this clinical trial is to to evaluate the effectiveness of prevention strategies of recurrence in DFU's. It will also to detect the risk level of recurrence. The main question it aims to answer are:

  • Does intervention of prevention strategies effective to prevent the recurrence of DFU's?
  • How the risk level of the recurrence on DFU's patients?
  • How the impact of quality of life on DFU's patients? Researchers will compare intervention groups (receiving education covered various aspects, including they received guidance on foot examination, foot care, dietary habits, physical exercise, and stress management), and control groups (received standards follow-up care provided by healthcare providers, including pamphlets outlining care for DM patients based on the five pillars, including DM management, medication adherence, dietary practices, physical exercise routines, and foot care). Participants will:
  • For intervention group will be educated every month
  • Data for both intervention and control groups were collected monthly until three months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 30, 2024

Completed
Last Updated

May 31, 2024

Status Verified

May 1, 2024

Enrollment Period

6 months

First QC Date

May 18, 2024

Last Update Submit

May 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • The degree of risk of recurrence

    The risk level recurrence ulcer tool, INDIFURUTO (Indonesian Diabetic Foot Ulcer Recurrence Assessment Tool), was used to assess the risk level. Subjects were categorized as high risk if they scored less than or equal to 22 points, medium risk if they scored between 23 and 45, and low risk if they scored more than or equal to 46.

    up to three months

  • Efficacy of prevention strategies

    Prevention stratagies is evaluated using INDIFURUTO tool (history of amputation, smoking, serum glucose levels, ankle-brachial index, monofilament test results, and differences in foot skin temperature). Good=INDIFURUTO total score increase than baseline and Poor=INDIFURUTO total score decrease than baseline

    up to three months

Secondary Outcomes (2)

  • Quality of life of DFU's

    up to three months

  • Health status of DFU's

    up to three months

Study Arms (2)

Prevention Strategies

EXPERIMENTAL

Groups received the prevention strategies to prevent the recurrence of DFU's

Device: Prevention Strategies

Standard Strategies

OTHER

Groups received the standard strategies to prevent the recurrence of DFU's

Device: Standard Strategiies

Interventions

Data collection sessions lasted approximately 1 to 1.50 hours, with education and foot care provided once a month. Subsequently, patients underwent monthly follow-ups for three months, during which they received guidance on foot examination, foot care, dietary habits, physical exercise, and stress management.

Prevention Strategies

Group were educated about DM management, medication adherence, dietary practices, physical exercise routines, and foot care through pamphlets

Standard Strategies

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Participants have a history of diabetic foot ulcers.
  • signed an informed consent

You may not qualify if:

  • Declined to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haryanto Haryanto

Pontianak, West Kalimantan, 78164, Indonesia

Location

Related Publications (1)

  • Haryanto H, Sari Y, Panjaitan E, Juminar J, Armstrong D. A Randomized Clinical Trial Study on the Prevention Strategy and Early Detection of Ulcer Recurrence in Patients with Type 2 Diabetes Mellitus Using the Risk of Recurrence Ulcer Tool. Int J Low Extrem Wounds. 2025 Sep;24(3):655-663. doi: 10.1177/15347346241283160. Epub 2024 Oct 21.

MeSH Terms

Conditions

RecurrenceDiabetic Foot

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Study Officials

  • Haryanto Haryanto

    ITEKES Muhammadiyah Kalimantan Barat

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The investigators known the groups.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Intervention group: patient education covered various aspects, including regular monitoring of blood glucose levels, effective dietary management, consistent physical activity, routine foot inspections, adherence to prescribed medications, and appropriate footwear selection based on plantar foot pressure measurements. During the intervention procedure, data collection sessions lasted approximately 1 to 1.50 hours, with education and foot care provided once a month. Subsequently, patients underwent monthly follow-ups for three months, during which they received guidance on foot examination, foot care, dietary habits, physical exercise, and stress management. Control group: Patients were educated about DM management, medication adherence, dietary practices, physical exercise routines, and foot care through pamphlets.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 18, 2024

First Posted

May 30, 2024

Study Start

January 1, 2023

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

May 31, 2024

Record last verified: 2024-05

Locations